loader image

Contributing to the Future of Biopharma Manufacturing

Table of Contents

Intro

We are proud to have contributed to a significant S$800 million (€558 million) Modulus project in Singapore by submitting and successfully placing contract candidates. This state-of-the-art facility, located in Tuas Biomedical Park, marks a pivotal step in redefining biopharmaceutical manufacturing and strengthens Singapore’s position in the global healthcare landscape.

About the facility

It’s Modulus facility in Singapore is Asia’s first of its kind, complementing a similar site completed in France. It represents a new generation of evolutive multi-product facilities that are modular, adaptable, and agile, leveraging disruptive technologies to address challenges in vaccine business and Specialty Care Biologics products. The facility incorporates a novel modular concept that shortens production timelines and allows for rapid changes in production capacities across different medicines.

A key focus of the Modulus facility is its high level of digitalisation and automation. It uses cutting-edge technology and advanced data analytics, with digital technology used to collect data in conjunction with science to improve and accelerate production. This includes technologies such as autonomous guided vehicles (AGVs), cobots, and cloud systems, enabling ‘paperless’ production and labs in some areas.

Furthermore, the facility is designed with sustainability at its core. It is a low-carbon facility and incorporates green technology, such as solar panels, the purchase of green electricity, and the use of recycled materials in its construction. This aligns with their broader commitment to Planet Care and its ambition for net zero greenhouse gas emissions by 2045, with a trajectory towards carbon neutrality by 2030. Sanofi aims for a 55% reduction in scopes 1 & 2 GHG emissions and a 30% reduction in scope 3 by 2030, and to source 100% renewable electricity by 2030.

The significance of the Modulus facility extends beyond manufacturing innovation. It strengthens the ability to rapidly develop and produce life-saving therapies and significantly bolsters pandemic preparedness by establishing the groundwork for crucial production modules. This investment underscores the companies commitment to providing patients faster access to existing and groundbreaking innovation, including future potential vaccines and biomedicines.

Our Contribution

The Modulus facility is expected to generate approximately 200 new jobs in Singapore. These roles span diverse areas critical to advanced biopharmaceutical manufacturing, including bioprocess engineers, automation specialists, data analysts, quality control experts, and specialists in artificial intelligence, machine learning, and bioinformatics.

Anter Consulting’s involvement in staffing this landmark project, as stated in the user’s query, means we have direct experience sourcing and placing candidates in critical roles within a cutting-edge, large-scale biopharma manufacturing environment. This experience is invaluable for future clients seeking expertise in:

 

    • Advanced Manufacturing Staffing: Navigating the unique talent needs of highly digitalised and automated production facilities, similar to Sanofi’s ‘Factory of the Future’ model.

    • Biopharmaceutical and Vaccine Production Roles: Identifying and placing skilled professionals required for manufacturing complex biological medicines and vaccines.

    • Digital and AI/ML Expertise: Sourcing talent proficient in the digital technologies, data analytics, AI, and machine learning being integrated into modern manufacturing and supply chains.

    • Sustainability-Focused Projects: Contributing personnel to projects prioritising environmental impact reduction, green technology, and sustainable practices within industrial settings.

    • Regional Expertise in Singapore and APAC: Leveraging insights gained from supporting a major project in Singapore, a key hub for biopharma expansion in Asia.

By successfully contributing to a project as significant and forward-thinking as Sanofi’s Modulus facility, Anter Consulting has demonstrated the capability to support complex staffing requirements in the most advanced sectors of healthcare and manufacturing. We are well-equipped to assist future clients looking for talent to drive innovation, sustainability, and efficiency in their operations.

You May Like These

The Role of Machine Learning in Compliance, Process, and Automation

Intro In today’s pharmaceutical landscape, efficiency, precision, and compliance are non-negotiable. Yet many operations—especially across biologics, API manufacturing, and validation—still...

From Months of Misses to a Perfect Match in 1 Week

“You found exactly what we were looking for — when no one else could.” – Words from client Background One...

AI in Pharmaceutical Drug Discovery: Driving Faster, Smarter Drug Development

AI in Pharmaceutical Drug Discovery: Driving Faster, Smarter Drug Development How AI is Accelerating Drug Development and Improving Patient Outcomes...

pexels-rfstudio-3825573
Read More
pexels-pixabay-532192
Read More
ArticleNews Thumbnails
Read More
pexels-rostislav-uzunov-5011647
Read More